Mutational Analysis of BRAFV600E by Polymerase Chain Reaction in Breast Cancer: A Narrative Review
Correspondence Address :
Dr. Simran Khan,
Department of Pathology, Jawaharlal Nehru Medical College, Sawangi (Meghe)-442005, Maharashtra, India.
E-mail: sabhatsimrankhan416@gmail.com
A major cause of cancer-related death for women globally is breast cancer, calling for molecular insights to better prognosis and treatment. One of the genetic changes that contributes to the constitutive activation of the MAPK/ERK (mitogen-activated protein kinase/extracellular signal-regulated kinase) pathway and promoting carcinogenesis is the BRAFV600E mutation, which has been extensively studied in melanoma. BRAFV600E has been associated with aggressive forms of breast cancer, including Triple-Negative Breast Cancer (TNBC), and worse clinical outcomes, despite its rarity. The Polymerase Chain Reaction (PCR)-based methods for analysing BRAFV600E mutations in breast cancer, specifically Invasive Ductal Carcinoma (IDC), are the main topic of this narrative review. The sensitivity and precision of different PCR techniques, such as droplet digital PCR (ddPCR), qPCR and traditional PCR, in identifying this mutation vary. The review emphasises BRAFV600E potential as a therapeutic target and prognostic marker, particularly considering the poorer efficacy of BRAF inhibitors in treating breast cancer than melanoma. The available data, which mostly comes from non Indian populations, highlights the need for additional thorough studies in a variety of populations, including Indian women, to fully comprehend the clinical significance of the mutation.
Invasive ductal carcinoma, Oncogene, Triple-negative tumour biomarkers
DOI: 10.7860/JCDR/2025/74252.20466
Date of Submission: Jul 13, 2024
Date of Peer Review: Oct 10, 2024
Date of Acceptance: Nov 08, 2024
Date of Publishing: Jan 01, 2025
AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was informed consent obtained from the subjects involved in the study? NA
• For any images presented appropriate consent has been obtained from the subjects. NA
PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Jul 15, 2024
• Manual Googling: Nov 04, 2024
• iThenticate Software: Nov 06, 2024 (10%)
ETYMOLOGY: Author Origin
EMENDATIONS: 4
- Emerging Sources Citation Index (Web of Science, thomsonreuters)
- Index Copernicus ICV 2017: 134.54
- Academic Search Complete Database
- Directory of Open Access Journals (DOAJ)
- Embase
- EBSCOhost
- Google Scholar
- HINARI Access to Research in Health Programme
- Indian Science Abstracts (ISA)
- Journal seek Database
- Popline (reproductive health literature)
- www.omnimedicalsearch.com